Madrigal Pharmaceuticals, Inc. logo

MDGL

Madrigal Pharmaceuticals, Inc.

$236.54

Earnings Summary

Revenue
$0Mn
Net Profits
$-98.74Mn
Net Profit Margins
-Inf%

Highlights

Revenue:

Madrigal Pharmaceuticals, Inc.’s revenue jumped NaN% since last year same period to $0Mn in the Q3 2023. On a quarterly growth basis, Madrigal Pharmaceuticals, Inc. has generated NaN% jump in its revenue since last 3-months.

Net Profits:

Madrigal Pharmaceuticals, Inc.’s net profit fell -19.4% since last year same period to $-98.74Mn in the Q3 2023. On a quarterly growth basis, Madrigal Pharmaceuticals, Inc. has generated -15.08% fall in its net profits since last 3-months.

Net Profit Margins:

Madrigal Pharmaceuticals, Inc.’s net profit margin jumped NaN% since last year same period to -Inf% in the Q3 2023. On a quarterly growth basis, Madrigal Pharmaceuticals, Inc. has generated NaN% jump in its net profit margins since last 3-months.

Earnings per share (EPS) Estimates

Earnings per share (EPS) estimates of the Madrigal Pharmaceuticals, Inc. post its latest quarter earnings

EPS Estimate Current Quarter
-5.66
EPS Estimate Current Year
-5.66

Highlights

EPS Estimate Current Quarter:

Madrigal Pharmaceuticals, Inc.’s earning per share (EPS) estimates for the current quarter stand at -5.66 - a -7.2% fall from last quarter’s estimates.

EPS Estimate Current Year:

Madrigal Pharmaceuticals, Inc.’s earning per share (EPS) estimates for the current year stand at -5.66.

Key Ratios

Key ratios of the Madrigal Pharmaceuticals, Inc. post its Q3 2023 earnings

Earning Per Share (EPS)
-5.34

Highlights

Earning Per Share (EPS):

Madrigal Pharmaceuticals, Inc.’s earning per share (EPS) fell -12.42% since last year same period to -5.34 in the Q3 2023. This indicates that the Madrigal Pharmaceuticals, Inc. has generated -12.42% annual rate of fall in its earning per share (EPS) in the last 4 quarters.

Earnings Calendar

Earnings DateEstimated EPSReported EPSSurprise %
2023-11-06
-4.93
-5.34
-8.32%
2023-08-08
-4.58
-4.69
-2.4%
2023-05-09
-4.94
-4.23
14.37%